Siemens made a giant leap for Alzheimer’s sufferers this year when they introduced a first-of-it’s-kind integrated system to diagnose early stage Alzheimer’s. This new process involves a newly FDA approved radiotracer that binds to beta-amyloid, a plaque found in the brains of Alzheimer’s patients. The plaque can then be seen with the help of the